Valuation: Pharmena S.A.

Market Cap 28.96M 7.71M 6.75M 6.23M 5.82M 10.96M 729M 11.21M 75.01M 360M 28.96M 28.32M 1.25B P/E 2023
2.73x
P/E 2024 -33.8x
Enterprise Value 27.46M 7.31M 6.4M 5.91M 5.52M 10.39M 691M 10.63M 71.12M 341M 27.46M 26.86M 1.18B EV / Sales 2023
191x
EV / Sales 2024 154x
Free-Float
29.7%
Yield 2023
12%
Yield 2024 22.2%
1 day+2.92%
1 week+0.63%
Current month-1.25%
1 month-1.25%
3 months-5.37%
6 months+22.87%
Current year+21.92%
1 week 3.06
Extreme 3.06
3.2
1 month 3.05
Extreme 3.05
3.3
Current year 2.56
Extreme 2.56
4.32
1 year 2.5
Extreme 2.5
4.32
3 years 2.5
Extreme 2.5
9.18
5 years 2.5
Extreme 2.5
13.7
10 years 2.5
Extreme 2.5
33.48
Manager TitleAgeSince
Chief Executive Officer - 12/11/2002
Chief Tech/Sci/R&D Officer - 01/04/2008
Director TitleAgeSince
Director/Board Member 62 -
Director/Board Member 63 -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
+2.92%+0.63%-7.31%-56.22% 9.13M
-0.24%+2.37%+8.98%-7.78% 236B
+4.24%+6.97%+56.79% - 51.73B
+6.34%+3.49%+159.58% - 8.86B
-0.29%+6.69%+1.92%-59.60% 6.36B
+3.68%+10.65%-44.66%-37.86% 4.01B
+14.95%+10.72%-15.02%+13.78% 3.93B
+1.85%+12.50%-16.63%-17.46% 3.46B
+1.69%-4.62%-30.36%-47.58% 3.27B
-0.16%+0.64%-22.90%-52.13% 2.42B
Average +3.50%+4.53%+9.04%-33.11% 32.03B
Weighted average by Cap. +0.94%+2.96%+18.85%-10.23%

Financials

2023 2024
Net sales 299K 79.62K 69.72K 64.36K 60.1K 113K 7.53M 116K 775K 3.71M 299K 292K 12.89M 268K 71.37K 62.49K 57.69K 53.87K 101K 6.75M 104K 694K 3.33M 268K 262K 11.56M
Net income 28.94M 7.71M 6.75M 6.23M 5.82M 10.95M 729M 11.2M 74.97M 359M 28.94M 28.31M 1.25B -1.26M -336K -294K -272K -254K -478K -31.77M -488K -3.27M -15.67M -1.26M -1.23M -54.42M
Net Debt -22.05M -5.87M -5.14M -4.75M -4.43M -8.35M -555M -8.54M -57.13M -274M -22.06M -21.57M -951M -1.5M -400K -350K -323K -302K -568K -37.79M -581K -3.89M -18.64M -1.5M -1.47M -64.73M
Logo Pharmena S.A.
Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
Employees
7
Date Price Change Volume
29/06/26 PLN 3.170 +2.92% 1,597
26/06/26 PLN 3.080 -3.14% 3,761
25/06/26 PLN 3.180 -0.31% 460
24/06/26 PLN 3.190 +0.31% 605
23/06/26 PLN 3.180 +0.95% 535